Skip to content

Transcranial Magnetic Stimulation for Low Back Pain

Clinical Applicaitons of Non-Invasive Brain Stimulation for the Treatment of Chronic Pain

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02070016
Enrollment
0
Registered
2014-02-24
Start date
2014-01-31
Completion date
2014-10-31
Last updated
2015-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Brief summary

The purpose of this study is to test whether non-invasive brain stimulation, such as Transcranial Magnetic Stimulation (TMS) may alleviate pain associated with various chronic pain conditions. We will test various methods of TMS to identify a treatment approach that may reduce the symptoms of chronic pain for the patient.

Interventions

DEVICETranscranial Magnetic Stimulation

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Patient with Chronic Low Back Pain * Meets minimum pain level criteria * Ability to perform the experimental Task and Procedures

Exclusion criteria

* MRI contraindication if an MRI exam is required per protocol * TMS Contraindication * History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher. * Neurologic illness that would interfere with brain integrity * Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher. * Currently pregnant or planning to become pregnant. * On going legal action or disability claim.

Design outcomes

Primary

MeasureTime frameDescription
Change in Average Daily PainBaseline Compared to each treatmeant series (at 4 weeks, 8 weeks, and 12 weeks)Compared to baseline pain report as provided by Visual Analogue Scale (VAS)
Change in Worst Daily PainBaseline Compared to each treatment series (at 4 weeks, 8 weeks, and 12 weeks)As compared to baseline worst daily pain report provided on visual analogue scale (VAS)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026